Skip to main content

Healthcare

The Economy Wiki

Beam Therapeutics is one of the leading companies in base editing, a next-generation gene editing approach designed to make precise single-base changes without creating double-strand DNA breaks. This technology gives Beam a differentiated position within genetic medicine.

Read More
The Economy Wiki

Bayer Pharmaceuticals remains a major global pharmaceutical business within Bayer AG, with strengths in cardiovascular medicine, ophthalmology, women’s health, oncology, hematology, and specialty care. Although Bayer as a group has faced significant pressures from its agricultural business and debt profile, its pharmaceutical division remains a relevant global platform.

Read More
The Economy Wiki

Bavarian Nordic is an established healthcare institution whose principal relevance to this ranking lies in commercial vaccines for infectious disease and preparedness. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in vaccine & Immunotherapy Developers.

Read More
The Economy Wiki

Axsome Therapeutics is an established healthcare institution whose principal relevance to this ranking lies in commercial neuroscience and central nervous system medicines. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biotechnology Firms.

Read More
The Economy Wiki

Avid Bioservices is a biologics CDMO focused on mammalian cell culture, process development, clinical manufacturing, commercial manufacturing, and related analytical services. The company serves biotechnology and pharmaceutical sponsors developing monoclonal antibodies, recombinant proteins, enzymes, and other biologic products.

Read More
The Economy Wiki

Avance Clinical is an Australian CRO focused on supporting biotechnology companies through early-phase and later-stage clinical development programs. The company is especially relevant for sponsors seeking to use Australia’s clinical trial environment, regulatory pathways, and investigator networks.

Read More
The Economy Wiki

Autolus Therapeutics is a London-headquartered cell-therapy company spun out of University College London in 2014. It develops programmed autologous T-cell therapies for cancer and autoimmune diseases. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in cell & Gene Therapy Developers.

Read More
The Economy Wiki

AstraZeneca Rare Disease, built around Alexion, remains one of the leading rare disease platforms globally. The business is especially associated with complement biology and severe rare disorders affecting hematology, nephrology, neurology, and metabolic disease.

Read More
The Economy Wiki

Astellas Pharma Inc. is a Tokyo-headquartered pharmaceutical company listed on the Tokyo Stock Exchange. Astellas was established in April 2005 by merging Yamanouchi Pharmaceutical, founded in 1923, and Fujisawa Pharmaceutical, founded in 1894.

Read More
The Economy Wiki

Ascendis Pharma is an established healthcare institution whose principal relevance to this ranking lies in endocrinology and rare-disease therapeutics using prodrug technology. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biotechnology Firms.

Read More
The Economy Wiki

Arrowhead Pharmaceuticals is an established healthcare institution whose principal relevance to this ranking lies in biotechnology firms. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biotechnology Firms.

Read More
The Economy Wiki

argenx has become one of the most important rare disease and specialty immunology developers globally. Its platform is focused on antibody-based medicines for severe autoimmune diseases, including rare neuromuscular and immune-mediated conditions requiring specialist care.

Read More
The Economy Wiki

Ardena is a pharmaceutical contract development and manufacturing organization (CDMO) and bioanalytical contract research organization (CRO) whose principal relevance to this ranking lies in small-molecule and nanomedicine development and manufacturing. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in biomanufacturing & CDMO Providers.

Read More
The Economy Wiki

Arcturus Therapeutics Holdings Inc. is a Nasdaq-listed RNA medicines company founded in 2013 and headquartered in San Diego, California. It develops RNA medicines and delivery technologies, including self-amplifying RNA vaccines. Its assessed scope here is vaccine and immunotherapy development.

Read More
The Economy Wiki

Arcellx is a specialist cell therapy developer focused on engineered cellular therapies for cancer, particularly multiple myeloma. Its lead program, anitocabtagene autoleucel, has become one of the most closely watched next-generation BCMA-directed CAR-T candidates.

Read More
The Economy Wiki

Apellis Pharmaceuticals is an established healthcare institution whose principal relevance to this ranking lies in complement-targeted therapies for rare hematologic and retinal diseases. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in rare Disease & Orphan Drug Developers.

Read More
The Economy Wiki

ANI Pharmaceuticals, Inc. develops, manufactures and markets branded and generic prescription medicines, including treatments for rare diseases. Its current public-company structure follows a June 2013 reverse acquisition involving BioSante and a July 2013 name change to ANI Pharmaceuticals.

Read More
The Economy Wiki

Amneal Pharmaceuticals is a global biopharmaceutical company whose principal relevance to this ranking lies in specialty and complex generic medicines. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in specialty Pharma Companies.

Read More
The Economy Wiki

Amicus Therapeutics is an established rare disease company focused on rare metabolic disorders, particularly Fabry disease and Pompe disease. The company has built its platform around precision therapy for genetically defined lysosomal storage and metabolic conditions.

Read More
The Economy Wiki

Amgen remains one of the most important biotechnology firms globally and one of the defining companies in the history of the modern biotechnology industry. The company has evolved from a pioneer of recombinant biologics into a global biopharmaceutical organization with substantial commercial scale, manufacturing depth, and pipeline breadth.

Read More